Literature DB >> 11528177

Heilbronn laparoscopic radical prostatectomy. Technique and results after 100 cases.

J Rassweiler1, L Sentker, O Seemann, M Hatzinger, C Stock, T Frede.   

Abstract

INTRODUCTION: In 1999, Guillonneau and Vallancien presented a refined approach of a descending laparoscopic radical prostatectomy which based mainly on the primary access to the seminal vesicles and an improved suturing and knotting technique. Based on our own experience reconstructive laparoscopy as well as with open retropubic radical prostatectomy we have used a combined ascending/descending technique similar to open surgery. In this paper we want to describe our approach and to present the initial results with the Heilbronn technique.
MATERIALS AND METHODS: A transperitoneal approach is used with a W-shaped arrangement of the trocars (13-mm umbilical port, 2 x 10 mm medial, 2 x 5 mm lateral ports). After the exposure of the Retzius' space and control of the dorsal vein complex the urethra is incised and the distal pedicles of the prostate (+/- the neurovascular bundle) are transsected. We now pull the apex ventrally and start with the incision at the bladder neck followed by a transvesical access to both vasa deferentia and seminal vesicles. The gland is entrapped in the Extraction Bag. After accomplishing the posterior wall of the urethrovesical anastomosis with five interrupted sutures, the foley catheter is placed into the bladder and the bladder neck is closed. Now the prostate is extracted via the umbilical incision. From March 1999 to June 2000, we have performed 100 cases (48 pT2-, 47 pT3- and 5 pT4 tumors). The mean preoperative PSA was 26.8 (1.4-75.5) ng/ml. Two tumors were grade 1, 72 grade 2 and 26 grade 3. Median Gleason score was 6 (3-9). All specimen were inked and examined according to the Stanford protocol. Postoperative continence was evaluated using a questionnaire monitored by a colleague who was involved in surgery.
RESULTS: We had 5 conversions (rectal injury, difficult dissection, adhesion, 2x bleeding at the dorsal vein complex). The mean operating time was 278 (180-500) min., the transfusion rate 31%. One patient required reintervention due to bleeding from the right obturator fossa. 95% of the patients did not require any analgesia on the second postoperative day. Positive margins were found in 17% of the patients, of which 12 had a PSA nadir to a value of less than 0.1 ng/ml within 3 weeks after surgery. In 82 patients, the anastomosis was tight after removal of the catheter, median catheter time was 8 (6-30) days. 4% developed a stricture at the anastomotic site which could be treated by laser incision. On discharge 33% were continent, after 6 months 81%, whereas only 2 patients still suffer from grade II stress incontinence at 9 months.
CONCLUSIONS: Laparoscopic radical prostatectomy is feasible but requires laparoscopic expertise. Its learning curve is still ongoing. Morbidity is low, oncological control is similar to results of open surgery, functional results are promising.

Entities:  

Mesh:

Year:  2001        PMID: 11528177     DOI: 10.1159/000049749

Source DB:  PubMed          Journal:  Eur Urol        ISSN: 0302-2838            Impact factor:   20.096


  20 in total

Review 1.  Laparoscopic radical prostatectomy: published series.

Authors:  András Hoznek; David B Samadi; Laurent Salomon; Alexandre De La Taille; Leif E Olsson; Clément-Claude Abbou
Journal:  Curr Urol Rep       Date:  2002-04       Impact factor: 3.092

2.  Laparoscopic radical prostatectomy.

Authors:  András Hoznek; David B Samadi; Laurent Salomon; Leif E Olsson; Fabien Saint; Dominique Chopin; Clément-Claude Abbou
Journal:  Curr Urol Rep       Date:  2002-04       Impact factor: 3.092

Review 3.  Evolution of endoscopic extraperitoneal radical prostatectomy (EERPE): technique and outcome.

Authors:  Jens-Uwe Stolzenburg; Odysseas Andrikopoulos; Panagiotis Kallidonis; Iason Kyriazis; Minh Do; Evangelos Liatsikos
Journal:  Asian J Androl       Date:  2011-12-19       Impact factor: 3.285

4.  [Radical prostatectomy - pro robotic].

Authors:  R Gillitzer
Journal:  Urologe A       Date:  2012-05       Impact factor: 0.639

Review 5.  Categorisation of complications of endoscopic extraperitoneal and laparoscopic transperitoneal radical prostatectomy.

Authors:  Jens-Uwe Stolzenburg; Robert Rabenalt; Minh Do; Benjamin Lee; Michael C Truss; Hartwig Schwaibold; Martin Burchardt; Udo Jonas; Evangelos N Liatsikos
Journal:  World J Urol       Date:  2006-01-06       Impact factor: 4.226

Review 6.  Complications of endoscopic extraperitoneal radical prostatectomy (EERPE): prevention and management.

Authors:  Jens-Uwe Stolzenburg; Robert Rabenalt; Minh Do; Benjamin Lee; Michael C Truss; Alan McNeill; Martin Burchardt; Udo Jonas; Evangelos N Liatsikos
Journal:  World J Urol       Date:  2006-11-04       Impact factor: 4.226

Review 7.  Oncological and functional results of open, robot-assisted and laparoscopic radical prostatectomy: does surgical approach and surgical experience matter?

Authors:  T R Herrmann; R Rabenalt; J U Stolzenburg; E N Liatsikos; F Imkamp; H Tezval; A J Gross; U Jonas; M Burchardt
Journal:  World J Urol       Date:  2007-03-13       Impact factor: 4.226

8.  Comparative study of the impact of 3- versus 8-month neoadjuvant hormonal therapy on outcome of laparoscopic radical prostatectomy.

Authors:  Xiao-Yong Pu; Xing-Huan Wang; Yi-Long Wu; Huai-Peng Wang
Journal:  J Cancer Res Clin Oncol       Date:  2007-04-25       Impact factor: 4.553

Review 9.  Surgical Management of Organ-Confined Prostate Cancer with Review of Literature and Evolving Evidence.

Authors:  Ahmed Saeed Goolam; Alfredo Harb-De la Rosa; Murugesan Manoharan
Journal:  Indian J Surg Oncol       Date:  2017-01-13

Review 10.  Prevention and management of perioperative complications in laparoscopic and endoscopic radical prostatectomy.

Authors:  Evangelos Liatsikos; Robert Rabenalt; Martin Burchardt; Miguel-Ramirez Backhaus; Minh Do; Anja Dietel; Johanna Wasserscheid; Costantinos Constantinides; Panagiotis Kallidonis; Michael C Truss; Thomas R Herrmann; Roman Ganzer; Jens-Uwe Stolzenburg
Journal:  World J Urol       Date:  2008-09-10       Impact factor: 4.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.